{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:52:58Z","timestamp":1775807578228,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 81974400"],"award-info":[{"award-number":["Nos. 81974400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173068"],"award-info":[{"award-number":["82173068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11596-025-00101-8","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:30:30Z","timestamp":1753774230000},"page":"917-929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chop Deficiency Exacerbates Cyclophosphamide-Induced Overactive Bladder via Impaired Macrophage Apoptosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Ya-nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-you","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-quan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-1457","authenticated-orcid":false,"given":"Zhi-hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"1","key":"101_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodyn."},{"issue":"7","key":"101_CR2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","volume":"108","author":"DE Irwin","year":"2011","unstructured":"Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132\u20131138.","journal-title":"BJU Int."},{"issue":"2","key":"101_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mayocp.2019.11.024","volume":"95","author":"R Raju","year":"2020","unstructured":"Raju R, Linder BJ. Evaluation and Treatment of Overactive Bladder in Women. Mayo Clin Proc. 2020;95(2):370\u2013377.","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"101_CR4","first-page":"274","volume":"75","author":"HD Mitcheson","year":"2019","unstructured":"Mitcheson HD, Samanta S, Muldowney K, et al. Vibegron (RVT-901\/MK-4618\/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial. Eur Urol. 2019;75(2):274\u2013282.","journal-title":"Controlled Trial. Eur Urol."},{"issue":"1","key":"101_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12894-021-00809-4","volume":"21","author":"K Gill","year":"2021","unstructured":"Gill K, Horsley H, Swamy S, et al. A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome. BMC Urol. 2021;21(1):39.","journal-title":"BMC Urol."},{"issue":"1","key":"101_CR6","doi-asserted-by":"publisher","first-page":"F28","DOI":"10.1152\/ajprenal.00580.2015","volume":"311","author":"E Ma","year":"2016","unstructured":"Ma E, Vetter J, Bliss L, et al. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder. Am J Physiol Renal Physiol. 2016;311(1):F28\u2013F34.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"101_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","volume":"53","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis A, Jacques TS, Freeman A, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol. 2008;53(6):1245\u20131253.","journal-title":"Eur Urol."},{"issue":"3","key":"101_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1464-410X.2011.10769.x","volume":"110","author":"V Kupelian","year":"2012","unstructured":"Kupelian V, Rosen RC, Roehrborn CG, et al. Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU Int. 2012;110(3):401\u2013407.","journal-title":"BJU Int."},{"issue":"3","key":"101_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/nau.20938","volume":"30","author":"SD Chung","year":"2011","unstructured":"Chung SD, Liu HT, Lin H, et al. Elevation of serum c-reactive protein in patients with OAB and IC\/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn. 2011;30(3):417\u2013420.","journal-title":"Neurourol Urodyn."},{"issue":"8","key":"101_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ni.3790","volume":"18","author":"MG Netea","year":"2017","unstructured":"Netea MG, Balkwill F, Chonchol M, et al. A guiding map for inflammation. Nat Immunol. 2017;18(8):826\u2013831.","journal-title":"Nat Immunol."},{"key":"101_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123\u2013147.","journal-title":"Annu Rev Pathol."},{"key":"101_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","volume":"39","author":"MM Ravesloot-Chavez","year":"2021","unstructured":"Ravesloot-Chavez MM, Van Dis E, Stanley SA. The Innate Immune Response to Mycobacterium tuberculosis Infection. Annu Rev Immunol. 2021;39:611\u2013637.","journal-title":"Annu Rev Immunol."},{"issue":"9","key":"101_CR13","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u20136440.","journal-title":"J Cell Physiol."},{"issue":"15","key":"101_CR14","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1182\/blood-2013-01-478206","volume":"122","author":"EL Gautier","year":"2013","unstructured":"Gautier EL, Ivanov S, Lesnik P, et al. Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood. 2013;122(15):2714\u20132722.","journal-title":"Blood."},{"issue":"4","key":"101_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1194\/jlr.M055400","volume":"56","author":"S Yao","year":"2015","unstructured":"Yao S, Tian H, Miao C, et al. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway. J Lipid Res. 2015;56(4):836\u2013847.","journal-title":"J Lipid Res."},{"key":"101_CR16","doi-asserted-by":"publisher","first-page":"e1847","DOI":"10.1038\/cddis.2015.206","volume":"6","author":"M Zhang","year":"2015","unstructured":"Zhang M, Guo Y, Fu H, et al. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1\/TLR4\/NFkappaB\/IL-1beta signaling. Cell Death Dis. 2015;6:e1847.","journal-title":"Cell Death Dis."},{"issue":"5","key":"101_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/mt.2016.36","volume":"24","author":"Y Yao","year":"2016","unstructured":"Yao Y, Wang Y, Zhang Z, et al. Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production. Mol Ther. 2016;24(5):915\u2013925.","journal-title":"Mol Ther."},{"issue":"1","key":"101_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41598-020-80131-5","volume":"11","author":"YH Jiang","year":"2021","unstructured":"Jiang YH, Jhang JF, Hsu YH, et al. Urine biomarkers in ESSIC type 2 interstitial cystitis\/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm. Sci Rep. 2021;11(1):914.","journal-title":"Sci Rep."},{"issue":"1","key":"101_CR19","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1038\/s41598-024-63448-3","volume":"14","author":"B Wei","year":"2024","unstructured":"Wei B, Zhao Y, Lin P, et al. The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci Rep. 2024;14(1):12579.","journal-title":"Sci Rep."},{"issue":"3","key":"101_CR20","doi-asserted-by":"publisher","first-page":"e0247861","DOI":"10.1371\/journal.pone.0247861","volume":"16","author":"Z Chen","year":"2021","unstructured":"Chen Z, Ognenovska S, Sluyter R, et al. Urinary cytokines in women with refractory detrusor overactivity: A longitudinal study of rotating antibiotic versus placebo treatment. PLoS One. 2021;16(3):e0247861.","journal-title":"PLoS One."},{"key":"101_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3389\/fnins.2018.00931","volume":"12","author":"L Grundy","year":"2018","unstructured":"Grundy L, Caldwell A, Brierley SM. Mechanisms Underlying Overactive Bladder and Interstitial Cystitis\/Painful Bladder Syndrome. Front Neurosci. 2018;12:931.","journal-title":"Front Neurosci."},{"issue":"1","key":"101_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12894-024-01435-6","volume":"24","author":"J Smith","year":"2024","unstructured":"Smith J, Tan JKH, Moro C. Mast cell distribution and prevalence in the murine urinary bladder. BMC Urol, 2024;24(1):51.","journal-title":"BMC Urol"},{"issue":"3","key":"101_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajpath.2012.05.035","volume":"181","author":"S Zhang","year":"2012","unstructured":"Zhang S, Lv JW, Yang P, et al. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol. 2012;181(3):937\u2013946.","journal-title":"Am J Pathol."},{"key":"101_CR24","doi-asserted-by":"publisher","first-page":"5205759","DOI":"10.1155\/2021\/5205759","volume":"2021","author":"LL Chen","year":"2021","unstructured":"Chen LL, Lee MH, Chang CL, et al. Suppression of Inflammatory and Fibrotic Signals by Cinnamon (Cinnamomum cassia) and Cinnamaldehyde in Cyclophosphamide-Induced Overactive Bladder in Mice. Evid Based Complement Alternat Med. 2021;2021:5205759.","journal-title":"Evid Based Complement Alternat Med."},{"issue":"2","key":"101_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tjog.2020.01.013","volume":"59","author":"YH Chen","year":"2020","unstructured":"Chen YH, Chen WC, Liu PL, et al. Astragalus polysaccharides and astragaloside IV ameliorates cyclophosphamide-induced mouse model of overactive bladder. Taiwan J Obstet Gynecol. 2020;59(2):248\u2013255.","journal-title":"Taiwan J Obstet Gynecol."},{"key":"101_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-pharmtox-010814-124536","volume":"55","author":"MC Michel","year":"2015","unstructured":"Michel MC. Therapeutic modulation of urinary bladder function: multiple targets at multiple levels. Annu Rev Pharmacol Toxicol. 2015;55:269\u2013287.","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"4","key":"101_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.kint.2022.06.026","volume":"102","author":"FC Chang","year":"2022","unstructured":"Chang FC, Liu CH, Luo AJ, et al. Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells. Kidney Int. 2022;102(4):780\u2013797.","journal-title":"Kidney Int."},{"issue":"4","key":"101_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nri2528","volume":"9","author":"JW Pollard","year":"2009","unstructured":"Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4):259\u2013270.","journal-title":"Nat Rev Immunol."},{"issue":"3","key":"101_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tem.2019.01.002","volume":"30","author":"I Cakir","year":"2019","unstructured":"Cakir I, Nillni EA. Endoplasmic Reticulum Stress, the Hypothalamus, and Energy Balance. Trends Endocrinol Metab. 2019;30(3):163\u2013176.","journal-title":"Trends Endocrinol Metab."},{"key":"101_CR30","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3389\/fimmu.2017.01612","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang Y, Liu L, Naik I, et al. Transcription Factor C\/EBP Homologous Protein in Health and Diseases. Front Immunol. 2017,8:1612.","journal-title":"Front Immunol."},{"issue":"6","key":"101_CR31","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jaci.2017.01.024","volume":"140","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhu J, Zhang L, et al. Role of C\/EBP homologous protein and endoplasmic reticulum stress in asthma exacerbation by regulating the IL-4\/signal transducer and activator of transcription 6\/transcription factor EC\/IL-4 receptor alpha positive feedback loop in M2 macrophages. J Allergy Clin Immunol. 2017;140(6):1550\u20131561.e8.","journal-title":"J Allergy Clin Immunol."},{"key":"101_CR32","doi-asserted-by":"publisher","first-page":"289519","DOI":"10.1155\/2015\/289519","volume":"2015","author":"B Chen","year":"2015","unstructured":"Chen B, Zhang H, Liu L, et al. PK2\/PKR1 Signaling Regulates Bladder Function and Sensation in Rats with Cyclophosphamide-Induced Cystitis. Mediators Inflamm. 2015;2015:289519.","journal-title":"Mediators Inflamm."},{"issue":"6","key":"101_CR33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.juro.2015.07.088","volume":"194","author":"CA Leite","year":"2015","unstructured":"Leite CA, Alencar VT, Melo DL, et al. Target Inhibition of IL-1 Receptor Prevents Ifosfamide Induced Hemorrhagic Cystitis in Mice. J Urol. 2015;194(6):1777\u20131786.","journal-title":"J Urol."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T15:27:21Z","timestamp":1758727641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00101-8","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"The protocol for the animal experiments in this study was approved by the Animal Ethics Committee of Tongji Hospital (approval number TJH-201906016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The study involving human samples was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (TJ-IRB20201008).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}